AbbVie completes the acquisition of Allergan company

Company AbbVie announced the completion of the acquisition of Allergan company after receiving regulatory approval from all government authorities, and the approval of the Supreme court of Ireland. The transaction value is estimated at 63 billion dollars.

Diversified portfolio of drugs was formed after the merger of the two companies, will allow to increase its existing platform growth AbbVie with approximately 30 billion dollars in revenue for the full year 2020 to total revenues of approximately $ 50 billion. It will also allow the company to increase the long-term growth potential to increase dividends and to invest in innovation in various therapeutic areas. The company expects quick repayment of additional debt through increased operating cash flows.

In connection with the closing of the transaction, the Board of Directors of AbbVie has elected a new member of the Board of Directors Thomas K. Freiman, who retired from the position of Executive Vice President and chief financial officer of Abbott. Freiman was a member of the Board of Directors of Allergan.

Leave a Reply

Your email address will not be published. Required fields are marked *


For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]